What's New At Kivara
Stay informed with the latest announcements, scientific milestones, research collaborations, and company developments as Kivara Neurosciences advances next-generation molecular diagnostics for neurodegenerative disease. Explore our progress in biomarker discovery, strategic partnerships, clinical development, and the evolution of the Intercept IQ™ platform.
Press Releases
- April 22, 2026
Kivara Neurosciences Announces Development of NeuroIntercept™, a Next-Generation Blood-Based Diagnostic Platform for Earlier Detection of Alzheimer's Disease
Company advances development of NeuroIntercept™, leveraging the proprietary Intercept IQ™ molecular diagnostics platform to pursue earlier detection of neurodegenerative disease.
Scientific Updates
- Coming Soon
Scientific updates from the InterceptIQ™ platform.
Platform advances, biomarker discoveries, and methodological notes.
Research Milestones
- Coming Soon
NeuroIntercept™ program milestones.
Validation milestones, cohort updates, and data readouts.
Conference Presentations
- Coming Soon
Upcoming conference presentations.
Posters, talks, and panels at scientific meetings.
Media Coverage
- Coming Soon
Featured media coverage of Kivara Neurosciences.
Press features and interviews with company leadership.
Events
- Coming Soon
Investor and scientific events.
Open scientific forums and investor presentations.